Filing Details

Accession Number:
0001477449-23-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-06 16:13:10
Reporting Period:
2023-09-01
Accepted Time:
2023-09-06 16:13:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780955 Mala Murthy C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-01 3,369 $0.00 48,085 No 4 M Direct
Common Stock Acquisiton 2023-09-01 2,043 $0.00 50,128 No 4 M Direct
Common Stock Disposition 2023-09-05 3,221 $22.89 46,907 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2023-09-01 3,369 $0.00 3,369 $0.00
Common Stock Restricted Stock Units Disposition 2023-09-01 2,043 $0.00 2,043 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,214 No 4 M Direct
14,307 No 4 M Direct
Footnotes
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  3. On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  4. On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.